Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection.
Mostafa Akbarzadeh-KhiaviMitra TorabiLeila RahbarniaAzam SafaryPublished in: Infection (2021)
Baricitinib plus the standard of care treatment might be a potential strategy in hospitalized patients with severe COVID-19.